Summary

Eligibility
for people ages 18 years and up (full criteria)
Location
at Irvine, California and other locations
Dates
study started
study ends around
Principal Investigator
by Shaista Malik, M.D.

Description

Summary

A single-group, multi-center, non-randomized clinical trial will be conducted to assess the feasibility of implementing an enhanced virtual world-based cardiac rehabilitation (VWCR) program within a muti-site clinical trial.

Official Title

Destination Cardiac Rehab: A Multicenter Feasibility Clinical Trial of an Enhanced Virtual World-based Cardiac Rehabilitation Intervention to Improve Cardiovascular Health and Outcomes Among Cardiac Patients

Keywords

Cardiovascular Health, Virtual World-based Cardiac Rehabilitation (VWCR) program

Eligibility

You can join if…

Open to people ages 18 years and up

  • Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines (diagnosed within the preceding 12 months) to include one or more of the following:
    • Myocardial infarction
    • Coronary artery bypass surgery
    • Current stable angina (chest pain)
    • Heart valve repair or replacement
    • Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting
    • Heart or heart-lung transplant
    • Stable chronic heart failure
  • Receiving care at one of the participating CR centers
  • Age ≥18 years
  • Basic Internet navigation skills
  • Active email address
  • Access to Internet at home or public access (church, library, etc) for 3 virtual visits per week

You CAN'T join if...

  • High risk patients according to the AACVPR risk stratification given safety concern of unsupervised exercise
    • Patients receiving continuous inotropic support
    • Recent receipt of a mechanical support device
    • Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia)
    • Decompensated heart failure
    • Symptomatic valvular heart disease
    • Uncontrolled angina
    • Receiving continuous inotropic support
    • Presence of a mechanical circulatory support device
    • Decompensated heart failure
    • Symptomatic valvular heart disease
    • Uncontrolled angina
    • Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise
  • Pregnancy (due to associated hormonal and weight changes) per patient report
  • Visual/hearing impairment or mental disability that would preclude independent use of the VW platform
  • Non-English-speaking patients due to logistical challenges with real time translation over a virtual platform

Locations

  • University of California (UCI), Irvine
    Irvine California 92617 United States
  • Mayo Clinic
    Rochester Minnesota 55905 United States
  • Mayo Clinic
    Jacksonville Florida 32224 United States

Lead Scientist at UC Irvine

  • Shaista Malik, M.D.
    Professor, Susan Samueli Center for Integrative Medicine, School of Medicine. Authored (or co-authored) 88 research publications

Details

Status
not yet accepting patients
Start Date
Completion Date
(estimated)
Sponsor
Mayo Clinic
ID
NCT07095504
Study Type
Interventional
Participants
Expecting 15 study participants
Last Updated